ArticleIn vivo (Athens, Greece)

The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer.

Kazuki Otani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.